Estrogen-resistant prostatic cancer with bone metastases: palliative chemotherapy with 5-fluorouracil and cyclophosphamide
Küss, R.; Khoury, S.; Richard, F.; Fourcade, R.; Frantz, P.; Capelle, J.P.
La Nouvelle Presse Medicale 7(28): 2478-2479
1978
ISSN/ISBN: 0301-1518 PMID: 80785 Document Number: 130725
Document emailed within 1 workday
Related Documents
Tashiro, K.; Kondo, N.; Ikemoto, I. 1986: A case of complete remission of distant metastases of a renal pelvic tumor by combination chemotherapy with mitomycin, cyclophosphamide and 5-fluorouracil Hinyokika Kiyo. Acta Urologica Japonica 32(3): 449-453Closon, M.T.; Verbeke, L.; Kains, J.P.; Tijtgat, J.; Schallier, D. 1995: Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer Anticancer Research 15(2): 591-595
Abe, O.; Izuo, M.; Enomoto, K.; Kubo, K.; Koyama, H.; Sakai, K.; Terasawa, T.; Tominaga, T.; Nomura, Y. 1982: Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 866-873
Jurascheck, F. 1973: Vascular accidents of estrogen therapy for prostatic cancer metastases Journal d'Urologie et de Nephrologie 79(12 Part 2): 400-402
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Raevskiĭ, I.G. 1976: Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone Sovetskaia Meditsina 8: 112-114
Takeuchi, S.; Fukui, I.; Higashi, Y.; Andoh, M.; Kihara, K.; Kitahara, S.; Horiuchi, S.; Oshima, H. 1989: Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 35(9): 1513-1517
Pectasides, D.; Tsavdaridis, D.; Aggouridaki, C.; Tsavdaridou, V.; Visvikis, A.; Tsatalas, K.; Fountzilas, G. 1999: Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage Ii breast cancer patients Anticancer Research 19(4c): 3521-3526
Tanaka, Y.; Ohmori, Y.; Toki, T.; Okazaki, Y.; Ogoshi, S.; Ogawa, Y. 1995: A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen Nihon Geka Hokan. Archiv für Japanische Chirurgie 64(1): 15-22
Tucker, J.D.; Wyrobek, A.J.; Ashworth, L.K.; Christensen, M.L.; Burton, G.V.; Carrano, A.V.; Everson, R.B. 1990: Induction, accumulation, and persistence of sister chromatid exchanges in women with breast cancer receiving cyclophosphamide, adriamycin, and 5-fluorouracil chemotherapy Cancer Research 50(16): 4951-4956
Morishita, Y.; Kasakura, Y.; Fujii, M.; Kochi, M.; Sato, K.; Kobayashi, M.; Takayama, T. 2004: A case report of colon cancer with liver and lung metastases responding to combination chemotherapy with l-LV, 5-fluorouracil and CPT-11 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(3): 427-430
Bombardieri, E.; Setti, L.; Kirienko, M.; Antunovic, L.; Guglielmo, P.; Ciocia, G. 2015: Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(4): 381-399
Sugiyama, Y.; Saji, S.; Miya, K.; Fukada, D.; Umemoto, T.; Kunieda, K.; Takao, H.; Kato, M.; Tsuji, K. 1995: A new modality of locoregional chemotherapy based on biochemical double modulation of 5-fluorouracil with both leucovorin and cisplatin against liver metastases of colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(11): 1460-1463
Shitara, K.; Munakata, M.; Kudo, T.; Kasai, M.; Muto, O.; Okada, R.; Mitobe, S.; Ishiguro, A.; Sakuraba, H.; Ikami, I.; Sakata, Y. 2006: Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(13): 2033-2037
Sakamoto, S.; Kusuyama, H.; Numa, H.; Okada, K. 1989: Lung metastases of prostatic cancer vanished by early combined hormonal and chemotherapy: report of a case Hinyokika Kiyo. Acta Urologica Japonica 35(6): 1069-1073
Haesner, M.; Buchali, K.; Pink, V.; Lips, H. 1992: The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer NUKLEARMEDIZIN. Nuclear Medicine 31(2): 48-52
Langhammer, H.; Sintermann, R.; Hör, G.; Pabst, H.W. 1978: Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer Nuklearmedizin. Nuclear Medicine 17(3): 87-91
Klotz, H.P.; Weder, W.; Largiadèr, F. 1993: Local and systemic toxicity of intra-hepato-arterial chemotherapy for treatment of unresectable liver metastases of colorectal cancer with 5-Fluorouracil and high dose Leucovorin Helvetica Chirurgica Acta 60(1-2): 283-286
Kuwakado, S.; Takiuchi, H.; Goto, M.; Kawabe, S.; Ohta, S.; Kii, T.; Tanaka, T.; Nishitani, H.; Katsu, K.-i. 2006: A case of gastric cancer with multiple liver metastases resistant to TS-1 responding to chemotherapy with paclitaxel plus doxifluridine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(4): 513-515
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28